Changes from plenary report to adopted text

RemovedDirective 2004/37/EC

RemovedArticle 2 – paragraph 1 – point 6 (new), Article 18a – paragraph 7: (6) in Article 18a, paragraph 7 is replaced by the following: / “No later than 31 December 2023, the Commission shall, after consulting the ACSH, taking into account the RAC’s 2018 opinion and the latest developments in scientific knowledge, where appropriate, submit a legislative proposal to introduce a limit value for cobalt and inorganic cobalt compounds.”;

RemovedDirective 2004/37/EC

RemovedArticle 2 – paragraph 1 – point 7 (new), Article 18a – paragraph 7 a (new): (7) in Article 18a, the following paragraph is added: / “By ... [one year after the date of entry into force of this amending Directive], the Commission shall, taking into account the latest developments in scientific knowledge and the opinion of the Committee for Risk Assessment of the European Chemicals Agency established by Regulation (EC) No 1907/2006, and after appropriate consultation of relevant stakeholders, prepare Union guidelines on how the implementation of the limit values referred to in Article 5(4a) are to be adapted in the case of exposure to a combination of substances. Those guidelines shall be published on the EU-OSHA website and shall be disseminated in all Member States by the relevant competent authorities.”;

RemovedDirective 2004/37/EC

RemovedArticle 2 – paragraph 1 – point 8 (new), Article 18a – point 7 b (new): (8) in Article 18a, the following paragraph is added: / “By ... [12 months after the date of entry into force of this amending directive], the Commission shall review the implementation of this Directive. In the context of that review, it shall consider whether further amendments to this Directive are appropriate, shall assess the feasibility of including endocrine disrupters within the scope of this Directive and shall, where appropriate, submit to the European Parliament and to the Council a legislative proposal.”;

RemovedDirective 2004/37/EC

RemovedArticle 2 – paragraph 1 – point 9 (new), Article 18a – paragraph 7 c (new): (9) in Article 18a, the following paragraph is added: / ‘By... [five years after the date of entry into force of this amending directive] and every five years thereafter, the Commission shall review the Occupational Exposure Limit Value and the Biological Limit Values including the limit value for historical exposure and the guidance value for female workers of childbearing age, laid down in Annex III and IIIa, taking into account the negative impacts on the reproductive capacity of female workers of childbearing age as well as on foetal development in order to ensure equal protection for all workers regardless of their gender as well as taking into account up-to-date scientific data and the classification of lead as a non-threshold reprotoxic.’

RemovedDirective 2004/37/EC

RemovedArticle 2 – paragraph 1 – point 10 (new), Article 18a – paragraph 7 d (new): (10) in Article 18a, the following paragraph is added: / “By ... [twelve months after the date of entry into force of this amending Directive], the Commission shall, after consulting the Advisory Committee for Safety and Health at Work (ACSH), develop a definition of ‘carcinogenic occupations’ and assess the appropriateness to include such occupations in the scope of this Directive.”;

RemovedDirective 2004/37/EC

RemovedArticle 2 – paragraph 1 – point 11 (new), Article 18a – paragraph 7 e (new): (11) in Article 18a, the following paragraph is added: / “By ... [twelve months after the date of entry into force of this amending Directive], the Commission shall, after consulting the ACSH, develop guidelines as regards historical occupational exposure to lead with a view to increasing the protection and reduction of the exposure of workers whose blood-lead levels are above the biological limit value as well as to further protect female workers of childbearing age. Those guidelines shall be published on the EU-OSHA website and shall be disseminated in all Member States by the relevant competent authorities.”

RemovedDirective 2004/37/EC

RemovedArticle 2 – paragraph 1 – point 12 (new), Article 18a – paragraph 7 f (new): (12) in Article 18a, the following paragraph is added: / “By [one year after the entry into force of this Directive], the Commission shall, after consulting the ACSH and taking into account existing recommendations made by relevant agencies, stakeholders and the World Health Organization with regard to priority carcinogens, mutagens and reprotoxic substances for which limit values are needed, revise its action plan to achieve occupational exposure limits values for substances, or groups of substances or process-generated substances additional to those referred to in this Directive. This shall in particular include lithium and lithium compounds, methyl hydrazine, 1,3-propanesultone, welding fumes and leather dust. By [two years after the entry into force of this Directive], the Commission shall, taking into account that revised action plan to achieve limit values for additional substances or group of substances or process-generated substances, the latest developments in scientific knowledge, and after consulting the ACSH, submit to the European Parliament and the Council, where appropriate, a legislative proposal.”;

RemovedDirective 2004/37/EC

RemovedArticle 2 – paragraph 1 – point 13 (new), Article 18a – paragraph 7 g (new): (13) in Article 18a, the following paragraph is added: / “By ... [twelve months after the date of entry into force of this amending Directive], the Commission shall, in consultation with social partners, consider targeted and limited exemptions for cultural and heritage-related work activities to existing Occupational Exposure Limit Values and Biological Limit Values, and take appropriate action.”

RemovedDirective 2004/37/EC

RemovedArticle 2 – paragraph 1 – point 14 (new), Article 18a – paragraph 7 h (new): (14) in Article 18a, the following paragraph is added: / “By 1 January 2028, the Commission shall, taking into account the RAC’s 2018 opinion and the latest developments in scientific knowledge, assess the feasibility of a further reduction of the limit value for benzene and shall, by 1 January 2030, where appropriate, submit to the European Parliament and the Council the necessary legislative amendments to this Directive.”;

RemovedArticle 2 – paragraph 1: Annexes I, III and IIIa to Directive 2004/37/EC are amended in accordance with Annex II to this Directive.

RemovedDirective 98/24/EC

RemovedAnnex II – introductory wording: Annexes I, III and IIIa to Directive 2004/37/EC are amended as follows:

RemovedDirective 2004/37/EC

RemovedAnnex II – point -1 a (new), Annex I – title: (-1) in Annex I, the title is amended as follows: / "List of substances, preparations and processes / (Article 2(a)(ii), 2(b)(ii), 2(ba)(ii))”;

RemovedDirective 2004/37/EC

RemovedAnnex II – point -1 a (new), Annex I – point 8 a (new): (-1a) in Annex I, the following point is added: / “8a. Work involving exposure to hazardous medicinal products.”;

RemovedDirective 2004/37/EC

RemovedDirective 2004/37/EC

RemovedAnnex II – point 2, Annex IIIa: Lead and its inorganic compounds / If the results of the medical surveillance reveal a blood-lead level of a worker greater than 30 μg Pb/100 ml blood, the employer and the authority responsible for the health surveillance of that worker shall ensure that the worker is no longer exposed to lead in accordance with the guidelines developed pursuant to Article 18a. / If the results of the medical surveillance reveal a blood-lead level of a worker between 15-30 μg Pb/100 ml blood and if a declining trend towards the limit value in force is established, then that worker may continue working with tasks that involve exposure to lead. / Specific measures, shall be put in place with regard to risk management, including specific and regular health surveillance, high standards for personal protective equipment and regular blood-lead checks. Under the general requirement of Directive 2004/37/EC, employers are obliged to ensure the substitution of the substances when technically possible, the use of closed systems, or the reduction of exposure to as low as technically possible. / Medical surveillance is carried out regularly for all workers exposed to lead and its inorganic compounds. / (1) It is recommended that the blood lead level in female workers of childbearing age does not exceed the reference values of the general population not occupationally exposed to lead in the respective EU Member State. When national reference levels are not available, it is recommended that blood lead leve…